Patent · US Active

Pyrazolopyridine derivatives as anticancer agent

US8889711B2 · kind B2 · utility

46Cited by

1References

19Claims

0Family size

Assignee

PIERRE FABRE MÉDICAMENT · FR

Inventors

Karim Bedjeguelal · Toulouse, FR
Rémi Rabot · Toulouse, FR
El Bachir Kaloun · Roquettes, FR
Patrice Mayer · Toulouse, FR
Arnaud Marchand · Leuven, BE
Nicolas Rahier · Ayguesvives, FR
Philippe Schambel · Castres, FR
Hugues Bienayme · Lyon, FR

Key dates

Filing date	Oct 13, 2010
Grant date	Nov 18, 2014
Priority date	—
Expiry date	Mar 9, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention concerns compounds of following general formula (I): (Formula I) and their pharmaceutically acceptable salts, their method of preparation and their uses, notably as anticancer agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.